Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Renascience Inc.. A complete text table follows the diagram.
Current business revenue is still small, but public funding, university alliances and late-stage trials are converting medical research into potential commercial assets.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Medical innovation platform | 1 | 10M | 100.0% of reported total |
| Business revenue | 2 | 10M | Six-month revenue from a clinical-stage medical-innovation company |
| From | To | Value |
|---|---|---|
| Medical innovation platform | Business revenue | 10M |